Bringing the fundamentals into focus…
Back to Collegium Pharmaceutical, Inc.
How Collegium Pharmaceutical, Inc. stacks up
COLL · against 482 other Healthcare companies of similar size
Profitability
92/ 100
Near the top of its peers.
Ranked #25 of 483 · scores higher than 94% of peers
Bars: peers in each 10-point band of the profitability score39 peers with a profitability score of 90–100, including COLL · Click a bar to see the companies
Why profitability scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital and operating margin, which are stronger than most Healthcare peers.
- Return on assets is close to the peer norm. Return on assets: 2.2% vs peer median 1.7%
- a wider operating margin: stronger than 80% of peers. Operating margin: 19.5% vs peer median 7.1%
- a higher return on invested capital: stronger than 97% of peers. Return on invested capital: 68.2% vs peer median 4.7%
Metric by metric
Position: dot = COLL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | COLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 458 reported | 68.2% | 3.3% | 98% | 33% | |
| Operating marginHigher is better · 450 reported | 19.5% | 5.5% | 86% | 33% | |
| Return on assetsHigher is better · 476 reported | 2.2% | 1.3% | 60% | 33% | |
| Return on equityHigher is better · 458 reported | 17.6% | 1.9% | 92% | Context only | |
| Gross marginHigher is better · 499 reported | 89.4% | 43.0% | 94% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around COLL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 21 | 31.0B THB (≈$867M) | 93 | 67 | |
| 21 | 913M USD | 93 | 77 | |
| 25 | 6.8B CNY (≈$950M) | 92 | 80 | |
| 25 | 19.6B TWD (≈$608M) | 92 | 70 | |
| 25 | 773M USD | 92 | 64 | |
| 25 | 14.41T IDR (≈$893M) | 92 | 69 | |
| 29 | 9.3B CNY (≈$1.3B) | 91 | 67 | |
| 29 | 3.8B HKD (≈$484M) | 91 | 65 | |
| 29 | 6.8B HKD (≈$872M) | 91 | 78 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score